Investors
Tandem Health has raised US$100m to expand its AI medical assistant and develop a wider clinical operating system across Europe. The Swedish-based company has completed the Series B round, its first fundraising since securing US$50m in a Series A last year. Tandem Health was launched to reduce the administrative burden associated with clinical care by [...]
Implicity has raised €35m to expand its cardiac monitoring platform internationally, with a focus on the US and further development of its AI capabilities. The Paris-based health tech company plans to use the funding to scale its commercial operations and develop its next generation of heart failure prediction algorithms. Implicity specialises in remote cardiac monitoring [...]
Forus has raised US$150m in Series C funding to expand its AI-powered medication access platform into more medical specialties and care settings. The funding comes four months after the health tech company raised US$160m in a Series B round and brings its total funding to more than US$300m. Forus said the latest round values the [...]
Hope Care has raised US$7m in Series A funding to expand its remote patient monitoring business across Europe. The Portuguese start-up develops OpMA, a regulated remote patient monitoring and telehealth platform that combines data from medical devices, patient-reported information and clinical workflows. The platform supports monitoring programmes for a range of chronic diseases. [...]
By McDermott Will & Schulte Artificial intelligence is rapidly reshaping how healthcare and life sciences companies innovate, operate and invest. What was once viewed as a future consideration is now a present reality, with adoption accelerating at a pace that has exceeded expectations. Recent discussions, including those at our European Health and Life Sciences Symposium, [...]
A new investment group has launched with the aim of buying and permanently holding successful British medtech companies, offering their founders an alternative to selling to private equity firms or larger rivals. Qualeris, based in Birmingham, was founded by Peter Dines, a medtech chief executive, investor and board director with three decades of experience in [...]
Oura's revenue rose to US$1.2bn in the nine months to 30 June as the wearable maker moves towards a US IPO. A filing with the Securities and Exchange Commission on Thursday showed revenue increased from US$697m in the same nine-month period a year earlier. Oura has previously said it generated US$500m in revenue in 2024 [...]
Elucid has raised US$55m in Series D financing to expand its AI cardiovascular imaging platforms and advance BioIntegrated FFR-CT through FDA clearance. The Boston-based medical technology company said the oversubscribed round brings its total funding to approximately US$185m. The funding will support commercial expansion of Elucid's clinical platforms, further research and development, clinical studies and [...]
Revier Therapeutics has officially launched after closing a €6m seed round to support development of its preclinical cardiometabolic pipeline. The Heidelberg-based biotech is developing disease-modifying therapies for cardiometabolic diseases, initially focusing on heart failure with preserved ejection fraction (HFpEF) and atherosclerotic cardiovascular disease (ASCVD). Revier is developing small-molecule treatments that selectively target class IIa histone [...]
Clementine has raised €1.7m in seed funding to deepen its AI hearing care platform and expand partnerships with clinics and healthcare organisations. The Maastricht-based start-up has developed technology designed to help hearing clinics turn prospective patients into bookings. Founded in 2024 by founder and chief executive Vince van de Weijer, Clementine, also known as ClementineAI, [...]
